Enjoy complimentary customisation on priority with our Enterprise License!
The drug delivery devices market share is expected to increase by USD 77.26 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 6.28%.
This drug delivery devices market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers drug delivery devices market segmentation by route of administration (oral, injectable, pulmonary, and others) and geography (North America, Europe, Asia, and ROW). The drug delivery devices market report also offers information on several market vendors, including 3M Co., AbbVie Inc., Antares Pharma Inc., Becton Dickinson and Co., BIOCORP Production, F. Hoffmann La Roche Ltd., Johnson and Johnson Inc., Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. among others.
Download the Free Report Sample to Unlock the Drug Delivery Devices Market Size for the Forecast Period and Other Important Statistics
The growing prevalence of chronic conditions is notably driving the drug delivery devices market growth, although factors such as product recalls can pose a challenge to manufacturers and impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the drug delivery devices industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Drug Delivery Devices Market Driver
One of the key factors driving growth in the drug delivery devices market is the growing prevalence of chronic conditions. There is a growing prevalence of chronic diseases, such as diabetes, chronic kidney disease, cancer, arthritis, and Alzheimer's disease worldwide. Developed nations such as the US, Canada, the UK, Australia, France, Germany, and others are witnessing a continuous increase in the number of people diagnosed with such diseases. This can be attributed to the changes in the lifestyle and eating habits of consumers in these countries. The outbreak of COVID-19 was declared a pandemic by WHO on March 11, 2020. The number of COVID-19 cases in various countries across the world has steadily been increasing since then. The growing prevalence of chronic conditions such as cancer, diabetes, cardiovascular diseases, among others, will lead to an increased demand for drug delivery devices. This will drive the growth of the global drug delivery devices market during the forecast period.
Key Drug Delivery Devices Market Trend
The development of new drugs and vaccines for COVID-19 is another factor supporting the drug delivery devices market share growth. Since the outbreak of the COVID-19 pandemic in March 2020, the development of various drugs that provide therapeutic treatment of COVID-19 has accelerated globally. There are various drugs and vaccines that can be used for the treatment of COVID-19, which are in several stages of clinical trials. Drug delivery devices such as oral, injectable, and respiratory-based delivery devices have witnessed high demand since the outbreak of the COVID-19 pandemic. The increase in the development of new drugs and vaccines for COVID-19 will drive the growth of the global drug delivery devices market during the forecast period.
Key Drug Delivery Devices Market Challenge
The product recalls will be a major challenge for the manufacturers in the drug delivery devices market during the forecast period. The global drug delivery devices market is growing at a rapid pace. However, the increasing number of product recalls have been hindering market growth. When regulatory bodies or companies recall products, it can impact the sales and the company's brand image. Product recalls affect a company's revenue as well as its long-term prospects by hampering consumer confidence. This, in turn, impacts the sales of its products and leads to a loss of faith among users. It can create pitfalls such as low-volume generation and limited product demand, leading to significant financial losses for vendors. Thus, such market challenges can negatively impact the growth of the global drug delivery devices market.
This drug delivery devices market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global drug delivery devices market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the drug delivery devices market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the drug delivery devices market encompasses successful business strategies deployed by the key vendors. The drug delivery devices market is fragmented and the vendors are deploying growth strategies such as focusing on innovating their offerings and building capabilities continuously to compete in the market
3M Co. - The company offers drug delivery devices such as scotchpak liners, CoTran flim.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The drug delivery devices market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the drug delivery devices market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
The value chain of the pharmaceuticals market includes the following core components:
The report has further elucidated on other innovative approaches being followed by manufacturers to ensure a sustainable market presence.
For more insights on the market share of various regions Request for a FREE sample now!
40% of the market's growth will originate from North America during the forecast period. The US is the key market for drug delivery devices in North America. Market growth in this region will be faster than the growth of the market in the European and ROW regions.
The high prevalence of chronic diseases such as cancer, diabetes, arthritis, the increasing adoption of treatment for these diseases, the presence of a large number of pharmaceutical companies, and new product launches will facilitate the drug delivery devices market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
In 2020, the COVID-19 pandemic had a positive impact on the regional drug delivery devices market. The pandemic led to increased regional demand for oral, injectable, and pulmonary drug delivery systems. A prominent vendor in the market, Becton, Dickinson, and Company (BD), reported that it had the highest revenue share from its medication delivery systems in 2020.
To gain further insights on the market contribution of various segments Request for a FREE sample
The drug delivery devices market share growth by the oral segment will be significant during the forecast period. The oral route is preferred to administer drugs over other methods as it is safe, non-invasive, cost-effective, and easy to use. Factors such as the growing prevalence of chronic conditions such as cancer, cardiovascular diseases, diabetes, and infectious diseases are expected to drive the growth of this market segment during the forecast period.
This report provides an accurate prediction of the contribution of all the segments to the growth of the drug delivery devices market size and actionable market insights on post COVID-19 impact on each segment.
Injectable Drug Delivery Devices market - The market share is expected to increase by USD 22.29 billion from 2021 to 2026, at a CAGR of 8.48%.
Advanced Drug Delivery Systems market - The market share is expected to increase to USD 91.79 billion from 2021 to 2026, at a CAGR of 7.41%.
|
Drug Delivery Devices Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2021 |
|
Forecast period |
2022-2026 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 6.28% |
|
Market growth 2022-2026 |
$ 77.26 billion |
|
Market structure |
Fragmented |
|
YoY growth (%) |
4.69 |
|
Regional analysis |
North America, Europe, Asia, and ROW |
|
Performing market contribution |
North America at 40% |
|
Key consumer countries |
US, Germany, UK, China, and Japan |
|
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
|
Key companies profiled |
3M Co., AbbVie Inc., Antares Pharma Inc., Becton Dickinson and Co., BIOCORP Production, F. Hoffmann La Roche Ltd., Johnson and Johnson Inc., Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
***1. Executive Summary
**1.1 Market Overview
*Exhibit 01: Key Finding 1
*Exhibit 02: Key Finding 2
*Exhibit 03: Key Finding 3
*Exhibit 04: Key Finding 5
*Exhibit 05: Key Finding 6
*Exhibit 06: Key Finding 7
*Exhibit 07: Key Finding 8
***2. Market Landscape
**2.1 Market ecosystem
*Exhibit 08: Parent market
*Exhibit 09: Market characteristics
**2.2 Value chain analysis
*Exhibit 10: Value chain analysis:
*2.2.1 Research and Development (R&D)– Drug discovery
*2.2.2 Integration and product development
*2.2.3 Manufacturing
*2.2.4 Outbound logistics:
*2.2.5 Marketing and sales:
*2.2.6 Support services:
*2.2.7 Innovation
***3. Market Sizing
**3.1 Market definition
*Exhibit 11: Offerings of vendors included in the market definition
**3.2 Market size 2021
**3.3 Market segment analysis
*Exhibit 12: Market segments
**3.4 Market outlook: Forecast for 2021 - 2026
*Exhibit 13: Global - Market size and forecast 2021 - 2026 ($ billion)
*Exhibit 14: Global market: Year-over-year growth 2021 - 2026 (%)
***4. Five Forces Analysis
**4.1 Five Forces Summary
*Exhibit 15: Five forces analysis 2021 & 2026
**4.2 Bargaining power of buyers
*Exhibit 16: Bargaining power of buyers
**4.3 Bargaining power of suppliers
*Exhibit 17: Bargaining power of suppliers
**4.4 Threat of new entrants
*Exhibit 18: Threat of new entrants
**4.5 Threat of substitutes
*Exhibit 19: Threat of substitutes
**4.6 Threat of rivalry
*Exhibit 20: Threat of rivalry
**4.7 Market condition
*Exhibit 21: Market condition - Five forces 2021
***5 Market Segmentation by Route of administration
**5.1 Market segments
*Exhibit 22: Route of administration - Market share 2021-2026 (%)
**5.2 Comparison by Route of administration
*Exhibit 23: Comparison by Route of administration
**5.3 Oral - Market size and forecast 2021-2026
*Exhibit 24: Oral - Market size and forecast 2021-2026 ($ billion)
*Exhibit 25: Oral - Year-over-year growth 2021-2026 (%)
**5.4 Injectable - Market size and forecast 2021-2026
*Exhibit 26: Injectable - Market size and forecast 2021-2026 ($ billion)
*Exhibit 27: Injectable - Year-over-year growth 2021-2026 (%)
**5.5 Pulmonary - Market size and forecast 2021-2026
*Exhibit 28: Pulmonary - Market size and forecast 2021-2026 ($ billion)
*Exhibit 29: Pulmonary - Year-over-year growth 2021-2026 (%)
**5.6 Others - Market size and forecast 2021-2026
*Exhibit 30: Others - Market size and forecast 2021-2026 ($ billion)
*Exhibit 31: Others - Year-over-year growth 2021-2026 (%)
**5.7 Market opportunity by Route of administration
*Exhibit 32: Market opportunity by Route of administration
***6. Customer landscape
**6.1 Overview
*Technavio’s customer landscape matrix comparing Drivers or price sensitivity, Adoption lifecycle, importance in customer price basket, Adoption rate and Key purchase criteria
*Exhibit 33: ?Customer landscape?
***7. Geographic Landscape
**7.1 Geographic segmentation
*Exhibit 34: Market share by geography 2021-2026 (%)
**7.2 Geographic comparison
*Exhibit 35: Geographic comparison
**7.3 North America - Market size and forecast 2021-2026
*Exhibit 36: North America - Market size and forecast 2021-2026 ($ billion)
*Exhibit 37: North America - Year-over-year growth 2021-2026 (%)
**7.4 Europe - Market size and forecast 2021-2026
*Exhibit 38: Europe - Market size and forecast 2021-2026 ($ billion)
*Exhibit 39: Europe - Year-over-year growth 2021-2026 (%)
**7.5 Asia - Market size and forecast 2021-2026
*Exhibit 40: Asia - Market size and forecast 2021-2026 ($ billion)
*Exhibit 41: Asia - Year-over-year growth 2021-2026 (%)
**7.6 ROW - Market size and forecast 2021-2026
*Exhibit 42: ROW - Market size and forecast 2021-2026 ($ billion)
*Exhibit 43: ROW - Year-over-year growth 2021-2026 (%)
**7.7 Key leading countries
*Exhibit 44: Key leading countries
**7.8 Market opportunity by geography
*Exhibit 45: Market opportunity by geography
***8. Drivers, Challenges, and Trends
**8.1 Market drivers
*8.1.1 Growing prevalence of chronic conditions
*8.1.2 Increased strategic developments
*8.1.3 Increase in regulatory approvals for drug delivery devices
**8.2 Market challenges
*8.2.1 Product recalls can pose a challenge to manufacturers
*8.2.2 Lack of trained professionals to administer drugs
*8.2.3 Lack of proper healthcare infrastructure in developing countries
*Exhibit 46: Impact of drivers and challenges
**8.3 Market trends
*8.3.1 Development of new drugs and vaccines for COVID-19
*8.3.2 Rising adoption of self-injectable devices
*8.3.3 Growing adoption of advanced drug delivery systems
***9. Vendor Landscape
**9.1 Competitive Scenario
**9.2 Overview
*Exhibit 47: Vendor landscape
*The potential for the disruption of the market landscape was moderate in 2020, and its threat is expected to remain unchanged by 2025.
**9.3 Landscape disruption
*Exhibit 48: ?Landscape disruption?
*Exhibit 49: Industry risks
***10. Vendor Analysis
**10.1 Vendors covered
*Exhibit 50: Vendors covered
**10.2 Market positioning of vendors
*Exhibit 51: ?Market positioning of vendors?
*10.3 3M Co.
*Exhibit 52: 3M Co. - Overview
*Exhibit 53: 3M Co. - Business segments
*Exhibit 54: 3M Co.- Key news
*Exhibit 55: 3M Co. - Key offerings
*Exhibit 56: 3M Co. - Segment focus
**10.4 AbbVie Inc.
*Exhibit 57: AbbVie Inc. - Overview
*Exhibit 58: AbbVie Inc. - Business segments
*Exhibit 59: AbbVie Inc. - Key offerings
*Exhibit 60: AbbVie Inc. - Segment focus
**10.5 Antares Pharma Inc.
*Exhibit 61: Antares Pharma Inc. - Overview
*Exhibit 62: Antares Pharma Inc. - Business segments
*Exhibit 63: Antares Pharma Inc. - Key offerings
*Exhibit 64: Antares Pharma Inc. - Segment focus
**10.6 Becton Dickinson and Co.
*Exhibit 65: Becton Dickinson and Co. - Overview
*Exhibit 66: Becton Dickinson and Co. - Business segments
*Exhibit 67: Becton Dickinson and Co. - Key offerings
*Exhibit 68: Becton Dickinson and Co. - Segment focus
**10.7 BIOCORP Production
*Exhibit 69: BIOCORP Production - Overview
*Exhibit 70: BIOCORP Production - Business segments
*Exhibit 71: BIOCORP Production - Key offerings
*Exhibit 72: BIOCORP Production - Segment focus
*10.8 F. Hoffmann La Roche Ltd.
*Exhibit 73: F. Hoffmann La Roche Ltd. - Overview
*Exhibit 74: F. Hoffmann La Roche Ltd. - Business segments
*Exhibit 75: F. Hoffmann La Roche Ltd. - Key offerings
*Exhibit 76: F. Hoffmann La Roche Ltd. - Segment focus
**10.9 Johnson and Johnson Inc.
*Exhibit 77: Johnson and Johnson Inc. - Overview
*Exhibit 78: Johnson and Johnson Inc. - Business segments
*Exhibit 79: Johnson and Johnson Inc. - Key offerings
*Exhibit 80: Johnson and Johnson Inc. - Segment focus
**10.10 Novartis AG
*Exhibit 81: Novartis AG - Overview
*Exhibit 82: Novartis AG - Business segments
*Exhibit 83: Novartis AG.- Key news
*Exhibit 84: Novartis AG - Key offerings
*Exhibit 85: Novartis AG - Segment focus
**10.11 Pfizer Inc.
*Exhibit 86: Pfizer Inc. - Overview
*Exhibit 87: Pfizer Inc. - Business segments
*Exhibit 88: Pfizer Inc.- Key news
*Exhibit 89: Pfizer Inc. - Key offerings
*Exhibit 90: Pfizer Inc. - Segment focus
**10.12 Teva Pharmaceutical Industries Ltd.
*Exhibit 91: Teva Pharmaceutical Industries Ltd. - Overview
*Exhibit 92: Teva Pharmaceutical Industries Ltd. - Business segments
*Exhibit 93: Teva Pharmaceutical Industries Ltd. - Key offerings
*Exhibit 94: Teva Pharmaceutical Industries Ltd. - Segment focus
***11. Appendix
**11.1 Scope of the report
*11.1.1 ????Market definition
*11.1.2 ????Objectives
*11.1.3 Notes and Caveats
**11.2 Currency conversion rates for US$
*Exhibit 95: ?Currency conversion rates for US$?
**11.3 Research Methodology
*Exhibit 96: ?Research Methodology
*Exhibit 97: ??Validation techniques employed for market sizing?
*Exhibit 98: ??Information sources
**11.4 List of abbreviations
*Exhibit 99: List of abbreviations
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.